Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Evans

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Diabetes Care|September 26, 2013
Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetesAhmad Haidar, Daniela Elleri, Kavita Kumareswaran, et al.
Diabetologia|June 12, 2024
Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetesAlison D McNeilly, Jennifer R Gallagher, Mark L Evans, et al.
Diabetes Technology & Therapeutics|May 3, 2017
Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 DiabetesAli Emami, Malgorzata E Willinska, Hood Thabit, et al.
The Lancet. Healthy Longevity|April 1, 2022
Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover studyCharlotte K Boughton, Sara Hartnell, Hood Thabit, et al.
Acta Diabetologica|February 20, 2024
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp studyTherese W Fabricius, Clementine E M Verhulst, Peter L Kristensen, et al.
Diabetologia|November 10, 2025
Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetesCalum Forteath, Heather J Merchant, Cyril Kocherry, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 26, 2023
Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in EnglandRachel A Elliott, Gabriel Rogers, Mark L Evans, et al.
Diabetologia|July 22, 2022
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic reviewClementine E M Verhulst, Therese W Fabricius, Steven Teerenstra, et al.
Diabetes Technology & Therapeutics|February 5, 2024
Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 DiabetesBelma Haliloglu, Charlotte K Boughton, Rama Lakshman, et al.
Diabetes Care|January 18, 2020
Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 DiabetesLalantha Leelarathna, Hood Thabit, Malgorzata E Willinska, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Diabetes Care|September 26, 2013
Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetesAhmad Haidar, Daniela Elleri, Kavita Kumareswaran, et al.
Diabetologia|June 12, 2024
Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetesAlison D McNeilly, Jennifer R Gallagher, Mark L Evans, et al.
Diabetes Technology & Therapeutics|May 3, 2017
Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 DiabetesAli Emami, Malgorzata E Willinska, Hood Thabit, et al.
The Lancet. Healthy Longevity|April 1, 2022
Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover studyCharlotte K Boughton, Sara Hartnell, Hood Thabit, et al.
Acta Diabetologica|February 20, 2024
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp studyTherese W Fabricius, Clementine E M Verhulst, Peter L Kristensen, et al.
Diabetologia|November 10, 2025
Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetesCalum Forteath, Heather J Merchant, Cyril Kocherry, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 26, 2023
Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in EnglandRachel A Elliott, Gabriel Rogers, Mark L Evans, et al.
Diabetologia|July 22, 2022
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic reviewClementine E M Verhulst, Therese W Fabricius, Steven Teerenstra, et al.
Diabetes Technology & Therapeutics|February 5, 2024
Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 DiabetesBelma Haliloglu, Charlotte K Boughton, Rama Lakshman, et al.
Diabetes Care|January 18, 2020
Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 DiabetesLalantha Leelarathna, Hood Thabit, Malgorzata E Willinska, et al.
Pageof 12